Patient Selection for the Tolvaptan Therapy Among Those With Chronic Kidney Disease and Heart Failure

Therapeutic Apheresis and Dialysis - United Kingdom
doi 10.1111/1744-9987.12859
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Effects of Tolvaptan on Patients With Severe Chronic Kidney Disease Complicated by Congestive Heart Failure

Clinical and Experimental Nephrology
PhysiologyNephrology
2013English

Efficacy and Safety of Goreisan for Chronic Heart Failure Patients With Chronic Kidney Disease

Kampo Medicine
2019English

Patient With Chronic Heart Failure. Rational Choice of Therapy

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2017English

Selection for Advanced Heart Failure Therapy Is Associated With Better Patient Activation Before Selection

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2016English

The Outcomes of Chronic Kidney Disease and Heart Failure With Reduced Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Chronic Kidney Disease and the Risk of Heart Failure in Men

Circulation. Heart failure
MedicineCardiovascular MedicineCardiology
2011English

Efficacy of Tolvaptan in a Patient With Right-Sided Heart Failure and Renal Dysfunction Refractory to Diuretic Therapy

Journal of Cardiology Cases
Cardiovascular MedicineCardiology
2014English

Screening for Celiac Disease Among Patients With Chronic Kidney Disease

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2012English

Early Goal Directed Sepsis Management in Patients With Heart Failure and Concomitant Chronic Kidney Disease

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy